Brain Imaging In Human Aging, Alzheimer Disease And Other Disorders
Brain Imaging In Human Aging, Alzheimer Disease And Other Disorders
批准号:
7963870
负责人:
Stanley I. Rapoport
金额:
$16.34万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAgeAgingAgonistAllelesAlzheimer&aposs DiseaseApomorphineArachidonic AcidsAttention deficit hyperactivity disorderAutopsyBehaviorBlood flowBrainBrain imagingBrain regionCell membraneCerebrovascular CirculationCholinesterase InhibitorsClinicalCognitionConsumptionDiseaseDocosahexaenoic AcidsDopamineDopamine D2 ReceptorDopamine ReceptorDrug effect disorderFatty AcidsGeneticGoalsHealthHumanImageManuscriptsMeasuresMemoryMetabolismMethodsMicrogliaModelingNational Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismPathologic ProcessesPatientsPerformancePharmaceutical PreparationsPhysostigminePlasmaPlayPolyunsaturated Fatty AcidsPositron-Emission TomographyProcessProtocols documentationRadiolabeledRattusReaction TimeResearchResearch Ethics CommitteesResearch PersonnelRodentRoleScanningSenile PlaquesShort-Term MemorySignal TransductionSynapsesSynaptic TransmissionWaterbasebrain cellcholinergicdensitydisease diagnosisfrontal lobehealthy volunteerimaging modalityin vivoneocorticalneuroinflammationneuropathologyneurotransmissionpreclinical studypreventradiotracerreceptorresponsesynaptic functiontransmission processuptakevolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
IMAGING NEUROINFLAMMATION IN ALZHEIMER DISEASE
Postmortem studies demonstrate neuroinflammatory markers in Alzheimer disease, but our ability to image neuroinflammation in humans in vivo is limited. Based on studies in a rat model of neuroinflammation, we predicted that brain uptake of intravenously injected radiolabeled arachidonic acid (AA) would be elevated in patients with Alzheimer disease. We confirmed this prediction using positron emission tomography (PET) in 8 mildly-severely demented Alzheimer disease patients compared with 8 aged-matched controls. AA incorporation was elevated in neocortical brain regions known to have high densities of senile neuritic plaques and activated microglia. Cerebral blood flow was reduced by comparison in these regions. Our PET method, after confirmation, might be used to examine progression of neuroinflammation in Alzheimer and other diseases in which it plays a role, and disease response to medication (Ref. 1).
CHOLINERGIC MODULATION OF SYNAPTIC FUNCTION IN HEALTHY VOLUNTEERS
Frontal cortex blood flow, measured using PET and 15O-water, was elevated in relation to working memory-task difficulty in young healthy volunteers, in relation to prolongation of reaction time. Administration of the anticholinesterase, physostigmine, prevented these changes. Thus, cholinergic modulation of synaptic transmission enhanced memory performance and reduced effortful synaptic recruitment in the frontal cortex. These changes may be related to the usefulness of anticholinesterase treatment in patients with Alzheimer disease (Ref. 2 and 3).
IMAGING HUMAN BRAIN SIGNALING INVOLVING DOPAMINE
We are conducting a PET protocol with the NIMH to image brain signal transduction via AA, related to dopaminergic transmission, in adults with Attention Deficit Hyperactivity Disorder (ADHD) and age-matched controls. Apomorphine, a dopamine D2/D3 receptor agonist, is administered to activate AA signaling via D2 receptors, as proven in preclinical studies. We hypothesize that this signaling will be disturbed in ADHD patients, based on genetic evidence of their altered dopamine receptor and transporter alleles. We have completed scans on 6 normal volunteers and are evaluating the results.
REGIONAL DOCOSAHEXAENOIC ACID IMAGING IN THE HUMAN BRAIN
DHA is a nutritionally essential polyunsaturated fatty acid in brain cell membranes and participates in many brain metabolic processes. Being able to image its consumption in human health and disease would be useful. We are conducting a PET protocol together with NIAAA investigator to quantify brain DHA signaling and consumption in healthy volunteers, based on our preclinical studies. For the entire brain, the mean rate of DHA incorporation from plasma equals 3.8 mg/day (Ref. 4).
IMAGING HUMAN BRAIN SIGNALING INVOLVING DOPAMINE
We initiated a PET protocol with the NIMH to image brain signal transduction via arachidonic acid, related to dopaminergic transmission, in adults with Attention Deficit Hyperactivity Disorder (ADHD) and age-matched controls. Apomorphine, a dopamine D2/D3 receptor agonist, is administered to activate arachidonic acid signaling via D2 receptors, as proven in preclinical studies. We hypothesize that this signaling will be disturbed in ADHD patients, based on genetic evidence of their altered dopamine receptor and transporter alleles. We have completed scans on 6 normal volunteers and are evaluating the results.
REGIONAL DOCOSAHEXAENOIC ACID IMAGING IN THE HUMAN BRAIN
Docosahexaenoic acid (DHA) is a nutritionally essential polyunsaturated fatty acid in brain cell membranes and participates in many brain metabolic processes. Being able to image its consumption in human health and disease would be useful. We are conducting a PET protocol together with NIAAA investigator to quantify brain DHA signaling and consumption in healthy volunteers, based on our preclinical studies. For the entire brain, the mean rate of DHA incorporation from plasma equaled 3.8 mg/day. We are preparing a manuscript on this research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMAGING DECREASED BRAIN DOCOSAHEXAENOIC ACID METABOLISM AND SIGNALING
-
批准号:8361447
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2011
-
负责人:Stanley I. Rapoport
-
依托单位:
CEREBROSPINAL FLUID MARKERS OF AGING AND BRAIN DISEASE
-
批准号:6413958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
DOWN SYNDROME, NEURODEVELOPMENT & NEURODEGENERATION
-
批准号:6434775
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Mechanisms Of Action: Lithium And Other Antimanic Drugs
-
批准号:6521733
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Cerebrospinal Fluid Markers Of Aging And Brain Disease
-
批准号:6667885
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Mechanisms Of Action Of Lithium And Other Drugs In Bipol
-
批准号:6968662
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Brain Imaging In Human Aging, Alzheimer Disease And Rela
-
批准号:6968663
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Brain Imaging In Human Aging, Alzheimer Disease And Other Disorders
-
批准号:8552321
-
项目类别:
-
资助金额:$7.49万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Lipid Nutrition and the Brain
-
批准号:8931542
-
项目类别:
-
资助金额:$72.89万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Lipids in Human Brain Disease
-
批准号:8931543
-
项目类别:
-
资助金额:$54.67万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic Acid
-
批准号:7963868
-
项目类别:
-
资助金额:$42.9万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Lipids in Brain Disease: Animal Models
-
批准号:8148194
-
项目类别:
-
资助金额:$22.84万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
In vivo Metabolism of Liver and Heart
-
批准号:7132265
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Molecular Biology of Brain Aging and Disease
-
批准号:6431402
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
COGNITIVE & NEUROPHYSIOLOGICAL FUNCTION IN HEALTHY AGING
-
批准号:6434770
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Gene Expression Of Hsc70 And Hsp70 In Mammals
-
批准号:6667886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Ether Lipids In The Central Nervous System
-
批准号:6667888
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Brain Phospholipid Metabolism, In Relation To Function
-
批准号:6521726
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Lipid Nutrition and the Brain
-
批准号:7592000
-
项目类别:
-
资助金额:$68.82万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
Lipids in Human Brain Disease
-
批准号:8335863
-
项目类别:
-
资助金额:$51.73万
-
财政年份:--
-
负责人:Stanley I. Rapoport
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: